Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTatton Asset Management Regulatory News (TAM)

Share Price Information for Tatton Asset Management (TAM)

Share Price is delayed by 15 minutes
Get Live Data
720.00    -12.00 (-1.64%)
Bid:
722.00
Ask:
728.00
Spread: 6.00 (0.831%)
Market Cap: £437.09m
TAM Live PriceLast checked at - London Stock Exchange

Intraday Tatton Asset Management Share Chart

Directorate Change

23 Apr 2018 07:01

RNS Number : 6779L
Tatton Asset Management PLC
23 April 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain

 

23 April 2018

Tatton Asset Management plc (or the "Group")

Directorate Change

 

Tatton Asset Management plc (AIM: TAM), the on-platform discretionary fund management (DFM) and IFA support services business, announces that Noel Stubley has notified the Board of his intention to retire from his role as Chief Financial Officer on 30 April 2018. Noel has served as Chief Financial Officer since March 2012. He will remain with the Company in an advisory capacity until 31 July 2018 to ensure a smooth handover to his successor.

The Board is delighted to announce the appointment of Paul Edwards as Chief Financial Officer, to take effect when Noel Stubley steps down from the Board on 30 April 2018.

Paul Edwards joins the Board with effect from 1 May 2018. Paul has previously been Group Finance Director of a number of quoted companies, most recently on the main board of Scapa Group plc. He has also held a number of other senior finance roles in a broad range of listed and private companies.

Roger Cornick, Chairman of the Board, commented:

"The Board thanks Noel for his contribution to the success of the Company during his tenure. He helped lead the Company through its early development to the recent successful IPO and the Board wishes him well for the future. Paul brings considerable listed public company experience to the role which allied to his broad range of financial and operational expertise will greatly strengthen the management team."

 

The Company makes the following disclosures in relation to Paul Edwards' appointment.

Current directorships:

None

 

Other directorships held during the last five years:

SCAPA GROUP PLC

SCAPA UK LTD

FIRST WATER LTD

FIRST WATER RAMSBURY LTD

SCAPA (NO.2) LTD

PORRITTS & SPENCER LTD

SCAPA BLACKBURN LTD

SCAPA GENERAL PARTNER LTD

SCAPA DENVER (NORTH) LTD

SCAPA (SCHWEIZ) AG

SCAPA INDUTRADE (SCHWEIZ) AG

SCAPA ITALIA SPA

SCAPA GROUP HOLDINGS GMBH

LINDSAY & WILLIAMS LTD (Dissolved)

SCAPA HOLDINGS LTD (Dissolved)

SCAPA EUROPE LTD (Dissolved)

SCAPA POLYMERICS LTD (Dissolved)

 

There is no further information required to be disclosed under Schedule Two, paragraph (g)(i) to (viii) of the AIM Rules for Companies.

 

Enquiries:

Tatton Asset Management plc

 

Paul Hogarth (Chief Executive Officer)

+44 (0) 161 486 3441

Lothar Mentel (Chief Investment Officer)

 +44 (0) 161 486 3441

Roddi Vaughan-Thomas (Head of Communications)

 +44 (0) 20 7190 2952

 

 

Zeus Capital - Nomad and Broker

+44 (0) 20 3829 5000

Martin Green

 

Dan Bate

 

Pippa Underwood

 

 

 

Powerscourt - Financial PR

+44 (0) 20 7250 1446

Justin Griffiths

 

Mazar Masud

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUUUCUPRGAU
Date   Source Headline
18th Oct 20227:00 amRNSTrading Update and Notice of Results
26th Sep 202212:43 pmRNSIssue of Shares
7th Sep 20225:25 pmRNSIssue of shares
30th Aug 20227:28 amRNSPDMR Shareholding
18th Aug 20225:07 pmRNSHolding(s) in Company
17th Aug 20227:50 amRNSHolding(s) in Company
15th Aug 20227:00 amRNSCompletion of Acquisition, Issue of Shares and TVR
27th Jul 202211:28 amRNSResult of AGM
27th Jun 20227:00 amRNSNotice of AGM
20th Jun 20222:36 pmRNSOption Exercise and PDMR Dealings
15th Jun 20227:00 amRNSAudited Final Results - year ended 31 March 2022
31st May 20227:00 amRNSFinal Results Presentations
4th May 20227:00 amRNSPDMR Shareholding
28th Apr 202212:03 pmRNSPDMR Dealing
26th Apr 20227:00 amRNSPDMR Dealing
21st Apr 20224:40 pmRNSSecond Price Monitoring Extn
21st Apr 20224:35 pmRNSPrice Monitoring Extension
20th Apr 20227:00 amRNSTrading Update and Proposed Acquisition
19th Apr 202212:08 pmRNSTR-1
11th Mar 20227:00 amRNSHolding(s) in Company
24th Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20213:57 pmRNSPDMR Dealing
19th Nov 202110:30 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSInterim results for the six months to 30 Sept 2021
4th Nov 20217:00 amRNSInvestor Presentation covering Interim Results
1st Nov 20217:00 amRNSIssue of Equity and PDMR Dealing
19th Oct 20217:00 amRNSTrading Update and Notice of Results
21st Sep 20217:00 amRNSIssue of Shares and PDMR Dealing
20th Sep 20216:28 pmRNSHolding(s) in Company
20th Sep 20217:00 amRNSPDMR Dealings, Exercise of Options & TVR
15th Sep 20217:00 amRNSAcquisition and Strategic Distribution Partnership
13th Sep 20214:41 pmRNSSecond Price Monitoring Extn
13th Sep 20214:35 pmRNSPrice Monitoring Extension
3rd Sep 20212:51 pmRNSIssue of shares and PDMR Dealings
12th Aug 202110:06 amRNSHolding(s) in Company
2nd Aug 202112:09 pmRNSPDMR Dealing
26th Jul 202110:31 amRNSPDMR Dealing
21st Jul 202111:37 amRNSResult of AGM
24th Jun 20217:00 amRNSNotice of AGM
15th Jun 20217:00 amRNSFinal Results for the year ended 31 March 2021
1st Jun 20217:00 amRNSFinal Results Presentations
10th May 20211:21 pmRNSIssue of Shares
27th Apr 20217:00 amRNSBoard Changes
20th Apr 20217:00 amRNSTrading Update
19th Apr 20215:23 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSInterim results for the six months to 30 Sept 2020
12th Nov 20207:00 amRNSExercise of warrant
9th Nov 202011:48 amRNSCorrection: Issue of Shares
6th Nov 20204:04 pmRNSIssue of Shares
30th Oct 20207:00 amRNSHalf Year Results Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.